Chuikyo OKs Pricing Rule Revision for October Re-Pricing; Stemirac to Be Priced as Medicine

January 16, 2019
The Central Social Insurance Medical Council, a health ministry reimbursement policy panel better known as Chuikyo, on January 16 approved a revision of NHI drug pricing rules towards the October 2019 ad-hoc re-pricing associated with the consumption tax hike. The...read more